Akeso press releases
The latest press releases from Akeso (HKEX: 9926.HK), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Akeso release within minutes of publication.
- Listing
- HKEX: 9926.HK
- Latest release
- Nov 5, 2026
- On this page
- 3 newest releases
Latest Akeso press releases
- Ivonescimab Receives NMPA Priority Review for First-Line Biliary Tract Cancer
HONG KONG, Nov. 4, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that ivonescimab in combination with chemotherapy for the first-line treatment of locally advanced or metastatic bil…
- Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 2026 Presidential Symposium
HONG KONG, Oct. 25, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registrational Phase III HA…
- Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Becomes the 7th International Registrational Clinical Trial for Ivonescimab Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akes…
PPN World is independent and not affiliated with Akeso. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Akeso press releases?+
How do I get an alert when Akeso publishes a press release?+
Is this Akeso's official newsroom?+
Know the minute Akeso publishes
Watch Akeso, its competitors and its sector in one live feed, with email alerts — on the free plan.